| Identification | Back Directory | [Name]
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- | [CAS]
1407166-70-4 | [Synonyms]
NODA-GA-NHS ester
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- | [Molecular Formula]
C19H28N4O10 | [MOL File]
1407166-70-4.mol | [Molecular Weight]
472.45 |
| Hazard Information | Back Directory | [Uses]
NODAGA-NHS (NODA-GA-NHS ester) is a [64]Cu chelator and the dissociated form of DOTA-trastuzumab in vivo. NODAGA-NHS was added in 0.1 M borate buffer at a ratio of 5/20/100 and was able to effectively bind trastuzumab (10 mg/mL) (4°C, 20 h). The copper content of the [64]Cu-NODAGA-trastuzumab was up to 80%. After blood was drawn from the caudal vein of mice, [64]Cu-NODAGA-trastuzumab was injected and showed good tumor uptake in mice expressing HER2 tumors, showing good PET imaging tracking ability. | [IC 50]
RDC Bifunctional Chelator |
|
|